A new study on the long-term effects of cannabidiol (CBD) on roundworms has been published. Here's why it has some significance.Canada's Canopy Growth announced...
Jazz Pharmaceuticals subsidiary GW Pharmaceuticals has announced it has received approval in the UK for the use of Epidyolex to manage seizures associated with...
Australia's Cann Group (ASX:CAN) has entered into an agreement aiming to accelerate registration of a Schedule 3, over-the-counter cannabidiol (CBD) medicine in Australia.While it...